In order to further demonstrate the specificity of LASS6 in ovarian cancer, we integrated various clinical factors of ovarian cancer samples, such as clinical stage and patient age, in the TCGA database, and compared the differences in LASS6 transcription levels among different groups (Fig. 5A). Here, CERS6 is linked to ovarian carcinoma.